NF1 and sarcoma: The most frequently mutated gene in patients with sarcoma is the cell cycle/cell death regulator tumor suppressor TP53, followed by the Ras/MAPK pathway inhibitor neurofibromin 1 (NF1), and the DNA repair regulators breast cancer associated 1 and 2 (BRCA1 and BRCA2).